Accuracy of the Enhanced Liver Fibrosis test, and combination of the Enhanced Liver Fibrosis and non‐invasive tests for the diagnosis of advanced liver fibrosis in patients with non‐alcoholic fatty liver disease. Issue 6 (25th March 2020)

• Record Type: Journal Article
• Authors: Inadomi, Chika; Takahashi, Hirokazu; Ogawa, Yuji; Oeda, Satoshi; Imajo, Kento; Kubotsu, Yoshihito; Tanaka, Kenichi; Kessoku, Takaomi; Okada, Michiaki; Isoda, Hiroshi; Akiyama, Takumi; Fukushima, Hideaki; Yoneda, Masato; Anzai, Keizo; Aishima, Shinichi; Nakajima, Atsushi; Eguchi, Yuichiro
• Is Part Of: Hepatology research. Volume 50:Issue 6(2020)
• Page Start: 682
• Page End: 692
• Publication Date: 2020-03-25
• Subjects: combination algorithm -- non‐invasive test -- sequential algorithm -- vibration‐controlled transient elastography; Liver -- Diseases -- Periodicals; Liver Diseases -- Periodicals; Foie -- Maladies -- Périodiques; 616.362
• DOI: 10.1111/hepr.13495
• Languages: English
• ISSNs: 1386-6346

Abstract

Abstract : Aim: The Enhanced Liver Fibrosis (ELF) test comprises a logarithmic algorithm combining three serum markers of hepatic extracellular matrix metabolism. We aimed to evaluate the performance of ELF for the diagnosis of liver fibrosis and to compare it with that of liver stiffness measurement (LSM) by FibroScan in non‐alcoholic fatty liver disease. Methods: ELF cut‐off values for the diagnosis of advanced fibrosis were obtained using receiver operating characteristic analysis in patients with biopsy‐confirmed non‐alcoholic fatty liver disease (training set; n = 200). Diagnostic performance was analyzed in the training set and in a validation set ( n = 166), and compared with that of LSM in the FibroScan cohort ( n = 224). Results: The area under receiver operating characteristic curve was 0.81 for the diagnosis of advanced fibrosis, and the ELF cut‐off values were 9.34 with 90.4% sensitivity and 10.83 with 90.6% specificity in the training set, and 89.8% sensitivity and 85.5% specificity in the validation set. There was no significant difference in the area under the receiver operating characteristic curve between ELF and LSM (0.812 and 0.839). A combination of ELF (cut‐off 10.83) and LSM (cut‐off 11.45) increased the specificity to 97.9% and the positive predictive value, versus ELF alone. Sequential use of the Fibrosis‐4 index (cut‐off 2.67) and ELF (cut‐off 9.34) increased the sensitivity to 95.9%. Conclusions: ELF can identify advanced liver fibrosis in non‐alcoholic fatty liver disease, and its diagnostic accuracy is comparable to that of FibroScan. According to the clinical setting, combinations or sequential procedures using other non‐invasive tests complement the diagnostic performance of ELF for the identification of advanced fibrosis.